Clinical Trials Browser

Withdrawn × Sirolimus × Genitourinary × Clear all

NCT03298958 2019-06-12

Secondary Prevention Trial of Rapamycin in Patients With Resected Non-muscle Invasive Bladder Cancer

Phase 3 Withdrawn

Urinary Bladder Neoplasms

NCT00922129 2014-01-14

Effectiveness of Conversion to Sirolimus Versus Calcineurin Inhibitor (CNI) Reduction in Renal Transplant Patients With Prostate Cancer

Phase 2/3 Withdrawn

Prostatic Neoplasms